T&L Biotechnology

Product Name

Generic Name

Anti-Human CD137 mAb

Product Information

Expression Host

HEK293 cells

QC Testing Purity

> 90 % as determined by SDS-PAGE

Purification

Protein A purified from cell culture supernatant

Endotoxin Level

< 0.1EU per μg of the protein as determined by the LAL method

Formulation

Supplied as a 0.22μm filtered solution in PBS, PH 7.4.

Stability & Storage

24 months at 2℃ to 8℃.

Avoid repeated freeze-thaw cycles.

Background

4-1BB, also known as CD137, is an inducible cell surface receptor and one member of tumor necrosis factor receptor (tumor necrosis factor receptor, TNFR) superfamily. CD137 is encoded by the tumor necrosis factor receptor superfamily member 9 (TNFRSF9) gene and widely expressed on the surface of activated T cells and NK cells. Its ligand, CD137L, also a TNFSF member, is an inducible costimulatory receptor expressed by activated CD4 + and CD8 + T cells, NKT, NK cells, DC, macrophages, eosinophils, neutrophils and mast cells, especially on CD8 + T cells. CD137 / CD137L mediate immune responses by transmitting activation, proliferation, or apoptotic signals between immune cells.

The activation of CD137 can stimulate NK cell and T cell proliferation and generate anti-tumor activity, which produce durable memory responses. 4-1BB mAb can activate 4-1BB to recruit TNFR related factors TRAF1 and TRAF2. Then, TRAF1 and TRAF2 form a heterotrimer, which strengthen signal transduction through c-Jun N terminal kinase (JNK) or extracellular signal-regulated kinase (ERK) pathway. This heterotrimer can stimulate the proliferation of T cells and antigen-presenting cells, improve anti-tumor immune response of the body and secrete cytokines through the  transcription of NF-κB.

References 

1. Langstein J,Schwarz H. Identification of CD137 as a potent monocyte survival factor. Journal of leukocyte biology, 1999 , 65(6):829-833.

2. Kim,Hongheea ,wack K, yubum K, Beomb,Lee, Zang heea. Activation of c-Jun N-terminal Kinase by 4-1BB (CD137), a T Cell Co-stimulatory Molecule. Molecules and cells, 2000,10(3): 247-252.

3. Kienzle G, von Kempis J. CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes. International immunology. 2000,12(1): 73-82.

Trial dosage: A customer can apply for up to five samples a year (the actual trial dosage is determined by telephone or email communication).
Scope of use: Samples are limited to testing and research purposes.
Cost: Free for samples, customer is responsible for shipping and handling charges, reference cost is $50 in the US, €60 in the EU, and $50 in other countries.
How to apply: You can apply by telephone or by email (the email application should specify the sample name, item number, contact person, telephone number, consignee address, etc.).